Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Licenses CRISPR From Broad Institute for Ag-Bio Applications

NEW YORK (GenomeWeb) – Monsanto announced today that it has obtained a global, non-exclusive licensing agreement from the Broad Institute for agricultural applications of CRISPR genome editing technology.

CRISPR-based genome editing offers "site-directed integration of specific genes as well as the opportunity to enhance beneficial [plant characteristics] or remove undesired plant characteristics," Monsanto said in a statement.

"The license to CRISPR/Cas from the Broad Institute provides access to an exciting tool for our growing body of genome-editing research," Monsanto biotechnology lead Tom Adams added. "Genome-editing technology is complementary to our ongoing discovery research and provides an incredible resource to further unlock our world-leading germplasm and genome libraries."

Financial and other terms of the agreement were not disclosed.

Monsanto joins DuPont Pioneer and Calyxt in pursuing CRISPR/Cas9 for ag-bio applications. DuPont Pioneer has cross-licensed CRISPR/Cas9 technology with CRISPR technology firm Caribou Biosciences, and has licensed Cas9 technology from Lithuania's Vilnius University. Calyxt, a subsidiary of Cellectis, has licensed patents covering the use of CRISPR/Cas9 in plants from the University of Minnesota.

Last week, German pharmaceutical company Bayer announced plans for a $66 billion merger with Monsanto. Bayer's Crop Science division has partnered on plant genome-editing with Cellectis, but has not licensed any CRISPR/Cas9 technology. However, Bayer's Life Science Center has licensed CRISPR/Cas9 for certain biomedical applications.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.